ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
Provided By GlobeNewswire
Last update: Feb 28, 2025
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Raymond James Institutional Investor Conference on March 5, 2025, at 11:35 a.m. ET.
Read more at globenewswire.com19.64
-1.67 (-7.84%)
Find more stocks in the Stock Screener
ADMA Latest News and Analysis
6 days ago - ChartmillInvestors seeking growth at a reasonable cost should explore ADMA BIOLOGICS INC (NASDAQ:ADMA).Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.
